Stock Ratings / Health Care / OFIX / forecast

SI (42) CARL (39) NPCE (30) MOBI (46) ⌘ Pro Terminal →

Orthofix Medical Inc. (OFIX) 12-Month Stock Forecast & Price Target Cone

$10.24 +1.99% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $10.26

Orthofix Medical Inc. (OFIX) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $417.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $10.26 (+0.17%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 4.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY • 51.4% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-1.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OFIX)Realized 20D OHLCV Swing Band: ±8.9%

Deterministic 5-Pillar Attribution (55/100 Composite)

🔍 WHY OFIX SCORES 55/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (27% of score)

FRED Regime × Technicals: 20% of 52W Range • RSI-14 at 42.3 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (20% of score)

20D Institutional Volume Accumulation (±8.9% realized swing band)

▼ #1 Drag / Risk Factor: Cash Engine Quality8/20 pts (-12 pt drag)

Capital intensity & 0% operating margin leave 12 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$9.17+2.3% Next Q

Q2 (-2Q)

Grade C-$9.38+4.6% Next Q

Q3 (-1Q)

Grade C-$9.81+4.4% Next Q

Current

Grade D+$10.24-0.5% Hist 90D α

Trajectory: D (47) → D+ (55)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the OFIX Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 55/100 (D+) score, OFIX faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 66.3% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($9.39) or 200D SMA ($11.10) invalidates the momentum regime and cuts Target Base ($10.10) toward Bear Floor ($7.88).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OFIX• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “OFIX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 55%NO 45%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your OFIX Position Size: $10,000

Shares at $10.24: 976.6 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $7.88

$7,695

$-2,305 (-23.0%)

12M Consensus BaseTarget $10.10

$9,863

$-137 (-1.4%)

12M Bull Case BreakoutTarget $17.84

$17,422

+$7,422 (+74.2%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (32 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 6

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$11	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$17	69%	B
JP MorganUS Large-Cap Research	SELL	$9	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring OFIX)

✓Walkthrough of OFIX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

OFIX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.93%📐 HORIZONTAL RANGE

2026-10-30O $10.29H $10.29L $8.90C $10.24VOL 657.9K

RES: $12.51SUP: $8.33SMA50: $9.39SMA200: $11.10

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OFIX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 OFIX Butterfly Map → + Track OFIX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +2.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on OFIX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for OFIX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for OFIX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OFIX)

Health Care Rank #280 of 1016 ⚔️ SI vs OFIX Full Matrix →

1. Head-to-Head Health Care Peer Comparison (OFIX vs. SI, CARL, NPCE, MOBI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Orthofix Medical Inc. (OFIX) ranks #280 by composite RQD confidence (55/100, grade D+) and #475 by equity capitalization ($417.1M). Within this direct 5-issuer industry benchmark cohort, OFIX leads on earnings valuation at N/A trailing P/E, while OFIX leads on capital efficiency and profitability with -12.2% ROIC and 68.8% gross margin. OFIX currently leads its immediate peer cohort in composite quantitative strength at 55/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
OFIX ACTIVE Orthofix Medical Inc.	D+	55/100	—	68.8%	-12.2%	+1.99%	$417.1M	Benchmark Subject
SI Shoulder Innovations Inc.	D-	42/100	—	76.5%	-16.1%	+4.93%	$425.5M	/si-vs-ofix →
CARL Carlsmed Inc.	D-	39/100	—	75.3%	-35.0%	+3.01%	$430.6M	/carl-vs-ofix →
NPCE Neuropace Inc.	E	30/100	—	77.2%	-23.0%	+0.62%	$446.6M	/npce-vs-ofix →
MOBI Mobia Medical Inc.	D	46/100	—	—	—	-4.41%	$375.2M	/mobi-vs-ofix →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000884624

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Orthofix Medical Inc. (OFIX) reported GAAP revenue of $822.3M (+2.9% vs. FY2024 revenue of $799.5M , and +10.1% cumulative change since FY2023) , GAAP net income of -$92.2M, operating cash flow of $33.3M, and free cash flow of $33.3M (+29.3% YoY). On the balance sheet, OFIX closed FY2025 with $850.6M in total assets against $157.4M in total debt (Altman Z-Score: 1.02, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$822.3M	-$92.2M	$33.3M	$33.3M	$850.6M	$157.4M
FY2024 (FY)	2024-12-31	$799.5M	-$126.0M	$25.8M	$25.8M	$893.3M	$157.0M
FY2023 (FY)	2023-12-31	$746.6M	-$151.4M	-$45.8M	-$45.8M	—	—

3. OFIX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OFIX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Orthofix Medical Inc. (NASDAQ: OFIX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $10.24 (+1.99% 1D, market cap $417.1M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, OFIX ranks #280 in composite RQD confidence.

How does OFIX compare to SI and CARL in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), OFIX carries a Roarable D+ (55/100 RQD), trailing P/E of N/A, gross margin of 68.8%, and ROIC of -12.2%. By comparison, SI (Shoulder Innovations Inc.) holds a D- grade (42/100 RQD, P/E N/A, ROIC -16.1%, cap $425.5M) and CARL (Carlsmed Inc.) posts a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $430.6M). Among the 5-stock peer group, OFIX leads on earnings multiple (N/A) while OFIX leads on capital efficiency (-12.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for OFIX?

Per OFIX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884624), Orthofix Medical Inc. generated $822.3M in revenue (+2.9% YoY), -$92.2M in net income, and $33.3M in free cash flow against $850.6M in total assets and $157.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is OFIX trading relative to its 50-day, 200-day, and 52-week technical levels?

OFIX last traded at $10.24 (+1.99% on volume of 399,270 shares), positioning the stock +9.05% above its 50-day simple moving average ($9.39) and -7.75% below its 200-day simple moving average ($11.10). Across its 52-week range of $8.50 to $16.99, OFIX sits at the 20.5% percentile with a 14-day RSI of 42.3 (NEUTRAL RANGE) and an implied next-earnings move of ±8.9% ($9.33 to $11.15).

OFIX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is OFIX's 12-month stock price target?

Orthofix Medical Inc. (OFIX) carries a 12-month consensus base price target of $10.1 (-1.4% from $10.24), with a bull-case target of $17.84 and a bear-case floor of $7.88.